๐Ÿ“–
Lipid nanoparticle-mediated transcription factor EB mRNA delivery for the treatment of metabolic dysfunction-associated steatotic liver disease.
Ju W, Zhang C, Zhang T, Liu Y, Wang X, Zeng L, Cao Y, Lin H, Li O, Wang PG, He Y, Lu H

Lipid nanoparticle-mediated transcription factor EB mRNA delivery for the treatment of metabolic dysfunction-associated steatotic liver disease.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Mol Biomed.

Advertisement
SPONSOR CONTENT
Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Lipid nanoparticle-mediated transcription factor EB mRNA delivery for the treatment of metabolic dysfunction-associated steatotic liver disease.
Author / Organization Ju W, Zhang C, Zhang T, Liu Y, Wang X, Zeng L, Cao Y, Lin H, Li O, Wang PG, He Y, Lu H
Subject & Discipline Mol Biomed
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-64321
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »